Businesses which rely on patents to protect their valuable innovations, or want to navigate intellectual property rights to access new markets, will have to fundamentally change how they approach patent enforcement and defensive strategies in Europe when the Unitary Patent and Unified Patent Court (UPC) go live in 2023.
The new court structure represents the biggest overhaul of the European patent system in history, and will present transformational opportunities for businesses.
Our experts investigate the implications of this game-changing new system.
Emmanuel Gougé is a renowned counsel and litigator in IP law, with a strong focus on patents, trade secrets and trademarks. Emmanuel has been involved in a range of multi-jurisdictional IP matters. His practice focuses mainly on electronics, automotive, aerospace, life sciences, and medical devices. Emmanuel has been involved in a wide range of cross-border litigations and has played an instrumental role in advising clients on multi-jurisdictional matters.
Rechtsanwalt, Partner, Head of German Life Sciences
Marc is Deputy Head of Pinsent Masons Germany. He also heads the German Life Sciences team. He specialises in supporting pharmaceutical, medical device and other high-tech companies in navigating through the complex world of contentious and non-contentious intellectual property.
Christopher is based in London and Dublin and is an IP litigation specialist. He graduated in Chemistry and spent time as a research chemist. His principal area of expertise is pharmaceutical patent litigation for both innovator and generic/biosimilar clients. Christopher has significant experience of leading multi-jurisdictional teams and managing and coordinating patent litigation.
Karen specialises in contentious intellectual property work, providing strategic advice to clients in complex patent disputes and trade mark, design and copyright litigation. Karen is a registered trade mark agent.